Skip to main content
. 2019 Jun 20;9:8837. doi: 10.1038/s41598-019-45311-y

Figure 1.

Figure 1

Blood levels of SCFAs in long-term MS (SPMS) patients versus healthy subjects. (A). Principle component analysis of the levels of 7 SCFAs determined by a targeted GC-MS approach. (B) A heatmap with Pearson correlation analysis for three major SCFAs. (C) Levels of SCFAs in the blood of SPMS patients and healthy control subjects. The data were obtained from the blood plasma of 15 healthy controls and 20 SPMS patients with comparable age ranges and male/female ratios. The boxplots display the 95% confidence intervals by Mann-Whitney test. P values are shown on top of each graph.